Updates matching "Access to Biomarker Testing"

After months of debate, state lawmakers have finalized New York’s state budget, opting to preserve access to biomarker testing for Medicaid enrollees. The adopted budget changed language in the historic biomarker testing law, initially passed in 2023, to clarify biomarker testing is covered when it is medically necessary. The law will retain the most important criteria used for determining when testing is to be covered, drawing praise from cancer survivors and patient advocates.

Cancer Advocates Applaud the State Legislature's Passage of Biomarker Testing Legislation, Ensuring Illinoisans Have Better Access to Personalized Care.

Late Friday, the Department of Health and Human Services (HHS) and the Centers for Medicare and Medicaid Services (CMS) released a final rule on the Patient Protection and Affordable Care Act HHS Notice of Benefit and Payment Parameters (NBPP) for plan year 2027. In March, the American Cancer Society Cancer

Cancer Advocates Gathered at the Statehouse Today to Say Ohio Can and Must Do Better to Reduce the Burden of Cancer

Visual Elements Available for Download: B-roll Soundbite with Ashley Fannin RALEIGH, N.C. – More than 50 cancer advocates, patients, survivors and caregivers from around the state gathered at the General Assembly on Tuesday, May 12 to ask lawmakers to make cancer policy a priority

NASHVILLE, Tenn. – Gov. Bill Lee signed House Bill 0484 into law Friday, thereby increasing access to biomarker testing for Tennesseans enrolled in state employee health insurance plans and TennCare. The American Cancer Society Cancer Action Network (ACS CAN) thanks lawmakers for their support of the bill,

RALEIGH, N.C. – Cancer advocates, patients, survivors and caregivers from around the state will gather at the General Assembly on Tuesday, May 12, to ask lawmakers to make cancer policy a priority for Cancer Action Day hosted by the American Cancer Society Cancer Action Network (ACS CAN). They will

Illinois Must Do Better to Reduce the Burden of Cancer

RALEIGH, N.C. – As North Carolina lawmakers begin the 2026 legislative session, the American Cancer Society Cancer Action Network (ACS CAN) urges them to prioritize HB567 , legislation that will ease the burden of cancer on North Carolinians by increasing access to biomarker testing for those with state-regulated health